CUBE Tech Fair welcomes spectacular speakers

CUBE10 - 12 May 2017, Berlin, Germany.
CUBE Tech Fair welcomes Brigitte Zypries, Germany's Federal Minister for Economic Affairs and Energy. CUBE is inspired by her work at the Ministry of Economics, in which she places a strong emphasis on advancing the Industry 4.0. She supports startups as well as SMBs (small & medium-sized businesses), where she promotes various financial instruments and network opportunities offered by the BMWi.

More Speakers

Samantha Payne

Founder of Open Bionics
Co-Founder of Open Bionics; an award-winning startup developing low-cost bionic hands that look and feel good, for amputees or those born without a hand. Now part of the Disney Accelerator, powered by Techstars. Samantha, recently named as one of the top 25 women in robotics you need to know about by Robohub and Marie Claire's Top Women In Tech. The startup has won multiple other awards for innovation, including being named one of the top 50 robotics businesses in the world alongside Google and Amazon.

Pablos Holman

Futurist, inventor, and notorious hacker.
He has helped create the world's smallest PC; 3D printers at Makerbot; & spaceships with Jeff Bezos. Currently, Pablos is working for Nathan Myhrvold & Bill Gates at the Intellectual Ventures Laboratory inventing solutions to the world's biggest problems.

Jonathan Yoni Ofir

CEO of LEAF
LEAF is the plug-n-plant™ system that automatically grows medical plants and food from the comfort of your home. Yoni founded LEAF in 2015 after he decided to build a growing system for his own needs and encountered overwhelming consumer demand. In September 2015 LEAF was the first ever cannabis startup to participate in Techrunch Disrupt Battlefield. LEAF was named Product Hunt 2016 Hardware Product of the Year and was featured on VICELAND's Weediquette.

Joseph Brunner

CEO of Relayr
Josef Brunner serves as relayr’s Chief Executive Officer. Josef has been instrumental in launching multiple IT and Cyber Security companies, like JouleX (2009) and Bastille Networks (2004). Before starting relayr, he completed his tenure with Cisco Systems, which began after the 2013 Cisco acquisition of JouleX, where he was Co-Founder and Chief Architect. Josef is also an active venture capitalist through his venture capital firm AFT Ventures.

World Pharma News readers can benefit from an exclusive discount - get 30% off the ticket price using our unique promo code worldpharmanewsCUBE17 when you register online here.

Hint: The faster you buy your ticket, the cheaper it is.

About CUBE
CUBE is a Berlin-based global innovation ecosystem that aims to promote, create and foster partnerships between industry players and startups in life sciences & digital health, machinery & manufacturing as well as infrastructure & connectivity. Being part of the CUBE ecosystem allows all participants to collaborate on innovative products and ideas in response to concrete industry needs.

The annual CUBE Tech Fair, our flagship event, will take place for the first time in May 2017. For further information, please visit http://tech-fair.cube-global.com.

Most Popular Now

Delivering insulin in a pill

Given the choice of taking a pill or injecting oneself with a needle, most of us would opt to regulate a chronic health condition by swallowing a pill. But for millions o...

Probiotics can protect the skeletons of older wome…

For the first time in the world, researchers at the University of Gothenburg, Sweden, have demonstrated that probiotics, dietary supplements with health-promoting bacteri...

Alzheimer's breakthrough: Brain metals that may dr…

Alzheimer's disease could be better treated, thanks to a breakthrough discovery of the properties of the metals in the brain involved in the progression of the neurodegen...

Can aspirin treat Alzheimer's?

A regimen of low-dose aspirin potentially may reduce plaques in the brain, which will reduce Alzheimer's disease pathology and protect memory, according to neurological r...

FDA approves first drug comprised of an active ing…

The U.S. Food and Drug Administration today approved Epidiolex (cannabidiol) [CBD] oral solution for the treatment of seizures associated with two rare and severe forms o...

In mice, stem cells seem to work in fighting obesi…

Obesity is an increasing global health problem associated with several comorbidities and a high risk of mortality. A wide spectrum of interventions has been proposed for ...

FDA takes steps to foster greater efficiency in bi…

Today, the agency withdrew the draft guidance, "Statistical Approaches to Evaluate Analytical Similarity," issued in September 2017. The draft guidance, if finalized as w...

Research shows how a moderate dose of alcohol prot…

For at least 20 years, research has shown that for many people, moderate consumption of alcohol can protect the heart, but the reason for this is poorly understood. A stu...

Some existing anti-cancer drugs may act in part by…

Bolstering the notion that RNA should be considered an important drug-discovery target, scientists at Scripps Research have found that several existing, FDA-approved anti...

'Kiss of death' cancer

It's called the 'kiss of death'. Triple negative breast cancer has no targeted drug therapy and, as such, the only hope for these patients is chemotherapy. Triple negativ...

Novartis Clear about Psoriasis survey data highlig…

Novartis announced today the publication of global Clear about Psoriasis survey data in the Journal of the European Academy of Dermatology and Venereology[1]. The publica...

Poliovirus therapy for recurrent glioblastoma has …

A genetically modified poliovirus therapy developed at Duke Cancer Institute shows significantly improved long-term survival for patients with recurrent glioblastoma, wit...